Marketing-authorisation holder · United States
Alpha Cognition
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ZUNVEYL10mg base | 15mg base | 5mg base · Tablet, delayed release | Benzgalantamine | United States | Marketed | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
U.S. Food and Drug Administration (Drugs@FDA, openFDA)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)



